Revium Rx (RVRC) Liabilities and Shareholders Equity (2024 - 2025)
Revium Rx (RVRC) reported Liabilities and Shareholders Equity of $8.3 million for Q4 2025, down 59.1% on a YoY basis from $20.3 million in Q4 2024, and down 59.1% sequentially from $20.3 million in Q4 2024.
Revium Rx (RVRC) Liabilities and Shareholders Equity (2024 - 2025) Analysis & Trends
Revium Rx (RVRC) has 2 years of Liabilities and Shareholders Equity data on file, last reported at $8.3 million in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Liabilities and Shareholders Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Veeva Systems | 31.81 Bn | 24.49 Bn | 662.02 Mn | 9.13 Bn |
| 2 | BrightSpring Health Services | 14.76 Bn | 13.86 Bn | 482.22 Mn | 6.21 Bn |
| 3 | Healthequity | 8.36 Bn | 8.10 Bn | 256.31 Mn | 3.31 Bn |
| 4 | Hinge Health | 5.91 Bn | 5.60 Bn | 154.23 Mn | 728.77 Mn |
| 5 | 10x Genomics | 5.89 Bn | 5.35 Bn | 106.18 Mn | 1.02 Bn |
| 6 | MiniMed | 4.45 Bn | 4.16 Bn | 480.00 Mn | 4.63 Bn |
| 7 | Waystar Holding | 4.41 Bn | 4.35 Bn | 216.84 Mn | 5.84 Bn |
| 8 | Doximity | 3.93 Bn | 3.18 Bn | 125.97 Mn | 1.12 Bn |
| 9 | Privia Health | 3.10 Bn | 2.68 Bn | - | 1.42 Bn |
| 10 | Revium Rx | 101.42 Mn | 98.71 Mn | - | 8.30 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 8.30 Mn |
| Dec 31, 2024 | 20.28 Mn |